Sensitivity analysis of the cerebrospinal fluid Visinin-like protein-1 (VLP-1) in Alzheimer’s disease patients relative to healthy controls and mild cognitive impairment patients. This evidence concerns the gene VSNL1 and Alzheimer disease.